Abstract
Among pituitary disorders having mass effect of the pituitary gland, nonfunctioning pituitary macroadenoma and lymphocytic hypophysitis are difficult to differentiate without histological examination. In order to efficiently distinguish lymphocytic hypophysitis and pituitary tumors, we studied the presence of autoantibodies against prohormone-processing enzymes, prohormone convertase (PC) 1/3, PC2, carboxypeptidase E (CPE), and PC2 regulatory protein, 7B2, by radioligand assay using recombinant human 35S-labeled protein in patients with clinically nonfunctioning pituitary macroadenoma, lymphocytic hypophysitis, and other pituitary diseases. The indexes for anti-PC1/3 antibodies (Ab) were significantly higher in patients with nonfunctioning pituitary macroadenoma than in patients with lymphocytic hypophysitis. Patients positive for either anti-PC1/3 or anti-7B2 Ab were significantly frequent among patients with nonfunctioning pituitary macroadenoma than in other pituitary diseases and healthy controls. None of the patients was positive for anti-PC2 Ab or anti-CPE Ab. These results suggest that autoantibodies against PC1/3 and 7B2 are novel tumor-associated autoantibodies and can be helpful in the diagnosis of clinically nonfunctioning pituitary macroadenoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Engelberth, O. and Jezkova, Z. (1965). Lancet 1, 1075.
Kikuchi, T., Yabe, S., Kanda, T., and Kobayashi, I. (2000). Endocr. J. 47, 407–416.
Takao, T., Nanamiya, W., Matsumoto, R., Asaba, K., Okabayashi, T., and Hashimoto, K. (2001). Horm. Res. 55, 288–292.
Crock, P. A. (1998). J. Clin. Endocrinol. Metab. 83, 609–618.
O’Dwyer, D. T., Smith, A. I., Matthew, M. L., et al. (2002). J. Clin. Endocrinol. Metab. 87, 752–757.
Crawford, L. V., Pim, D. C., and Bulbrook, R. D. (1982). Int. J. Cancer 30, 403–408.
Soussi, T. (2000). Cancer Res. 60, 1777–1788.
Sheikh, K. M., Weiss, M. H., and Quismorio, F. P. (1983). Neurol. Res. 5, 1–12.
Mau, M., Phillips, T. M., and Ratner, R. E. (1993). Clin. Endocrinol. (Oxf.) 38, 495–500.
Sawicka, J., Gryczynska, M., Baumann-Antczak, A., Gut, P., Polanska, A., and Kosowicz, J. (1999). Pol. Arch. Med. Wewn. 101, 123–129 (in Polish).
Tanaka, S., Tatsumi, K., Okubo, K., et al. (2002). J. Mol. Endocrinol. 28, 33–44.
Tanaka, S., Tatsumi, K., Kimura, M., et al. (2002). Eur. J. Endocrinol. 147, 767–775.
Tanaka, S., Tatsumi, K., Takano, T., et al. (2003). Endocr. J. 50, 697–702.
Ahmadi, J., Meyers, G. S., Segall, H. D., Sharma, O. P., and Hinton, D. R. (1995). Radiology 195, 30–34.
Hashimoto, K., Takao, T., and Makino, S. (1997). Endocr. J. 44, 1–10.
Beressi, N., Beressi, J. P., Cohen, R., and Modigliani, E. (1999). Ann. Med. Int. (Paris) 150, 327–341.
Powrie, J. K., Powell, M., Ayers, A. B., Lowy, C., and Sonksen, P. H. (1995). Clin. Endocrinol. (Oxf.) 42, 315–322.
Kristof, R. A., Van Roost, D., Klingmuller, D., Springer, W., and Schramm, J. (1999). J. Neurol. Neurosurg. Psychiatry 67, 398–402.
Nishiki, M., Murakami, Y., Ozawa, Y., and Kato, Y. (2001). Clin. Endocrinol. (Oxf.) 54, 327–333.
Voltz, R. (2002). Lancet Neurol. 1, 294–305.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tatsumi, Ki., Tanaka, S., Takano, T. et al. Frequent appearance of autoantibodies against prohormone convertase 1/3 and neuroendocrine protein 7B2 in patients with nonfunctioning pituitary macroadenoma. Endocr 22, 335–340 (2003). https://doi.org/10.1385/ENDO:22:3:335
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:22:3:335